Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. Άlvarez Payero"'
Autor:
J. De Uña Άlvarez, C. Barbazán Άlvarez, J.M. Pego Reigosa, M. Άlvarez Payero, G. Piñeiro Corrales, I. Hernández Rodriguez, R.B. Melero González, V. Balboa Barreiro, N. Martinez Lopez de Catro, M. Rodríguez Lόpez, Mérida Rodríguez, C. Mouriño, A. Martín Vila, M. Samartin Ucha, F. Maceiras Pan
Publikováno v:
Annals of the Rheumatic Diseases. 75:721.1-721
Objectives To analyze the reasons for discontinuation the biological treatment in a cohort of patients diagnosed with rheumatoid arthritis (RA), psoriatic arthritis (PA), ankylosing spondylitis (AS) and other spondyloarthropathies (O) that have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9c6f4b325598a7654cb789e20967c85
https://doi.org/10.1136/annrheumdis-2016-eular.4969
https://doi.org/10.1136/annrheumdis-2016-eular.4969
Autor:
J.M. Pego, Isabel Hernández, G. Piñeiro, A. Martin, V. Balboa, M. Άlvarez-Payero, C. Mouriño, M. Rodríguez-Rodríguez, F. Maceiras, J. Uña, N. Martínez, Rafael Melero, M. Ucha, C. Barbazán, M. Rodríguez
Publikováno v:
Annals of the Rheumatic Diseases. 75:1316.2-1316
Background Chronic inflammatory arthropaties-CIA (RA-rheumatoid arthritis, PA-psoriatic arthritis, and AS-ankylosing spondylitis) cause functional disability and reduces health-related quality of life (HRQoL) of patients1 Objectives To evaluate HRQoL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::458696095905ecda885a6c4e289615ce
https://doi.org/10.1136/annrheumdis-2016-eular.3761
https://doi.org/10.1136/annrheumdis-2016-eular.3761
Autor:
M. Rodríguez Lόpez, Mérida Rodríguez, C. Barbazán Άlvarez, C. Mouriño, A. Martín Vila, N. MartÍnez Lόpez de Castro, I. Hernández Rodriguez, M. Samartin Ucha, J. De Uña Άlvarez, J.M. Pego Reigosa, R.B. Melero González, V. Balboa Barreiro, F. Maceiras Pan, M. Άlvarez Payero, G. Piñeiro Corrales
Publikováno v:
Annals of the Rheumatic Diseases. 75:1017.1-1017
Objectives To analyze the survival of treatment lines with different biologics in a cohort of patients diagnosed with rheumatoid arthritis (RA), psoriatic arthritis (AP), ankylosing spondylitis (AS) and other spondyloarthropathies (O). Methods Retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::237a233b60667b00d3e57c3f534c6237
https://doi.org/10.1136/annrheumdis-2016-eular.5126
https://doi.org/10.1136/annrheumdis-2016-eular.5126